Contact

Get in touch

Our team does the best to answer as quickly as possible. Check our Frequently Asked Questions to find more about our service.

Explore our FAQs

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Begin your journey today

A new, healthier you awaits

Start Your Free Assessment

*Along with a reduced calorie diet and increased exercise. In a 68-week clinical study of Wegovy®, about 1 in 3 adults with obesity or with overweight and weight-related medical problems achieved 20% weight loss. Average weight loss achieved was 15%. Wegovy® is a registered trademark of Novo Nordisk A/S.
* Compounded drug products are not approved or evaluated for safety, efficacy, or quality by the FDA.
Wegovy® (semaglutide) and Ozempic® (semaglutide) are not compounded. Wegovy® (semaglutide) is FDA-approved for weight loss. Ozempic® (semaglutide) is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider’s discretion.A healthcare provider may prescribe a compounded drug if determined that it is medically appropriate and necessary for you.